Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C26H25N5O3 |
| Molecular Weight | 455.5084 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC=CC2=C1N(C(=O)N2[C@@H]3CCCN(C3)C(=O)C=C)C4=CC=C(OC5=CC=CC=C5)C=C4
InChI
InChIKey=KOEUOFPEZFUWRF-LJQANCHMSA-N
InChI=1S/C26H25N5O3/c1-2-23(32)29-16-6-7-19(17-29)30-22-14-15-28-25(27)24(22)31(26(30)33)18-10-12-21(13-11-18)34-20-8-4-3-5-9-20/h2-5,8-15,19H,1,6-7,16-17H2,(H2,27,28)/t19-/m1/s1
| Molecular Formula | C26H25N5O3 |
| Molecular Weight | 455.5084 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
7.1 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/37642857/ |
60 mg single, oral dose: 60 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
1.17 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
7.5 mg single, oral dose: 7.5 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
1.96 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
15 mg single, oral dose: 15 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
6.25 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
30 mg single, oral dose: 30 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
8.47 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
60 mg single, oral dose: 60 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
19.3 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
90 mg single, oral dose: 90 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
1.32 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
7.5 mg 1 times / day multiple, oral dose: 7.5 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
2.51 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
15 mg 1 times / day multiple, oral dose: 15 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
7.46 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
30 mg 1 times / day multiple, oral dose: 30 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
6.69 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
60 mg 1 times / day multiple, oral dose: 60 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
21.7 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
90 mg 1 times / day multiple, oral dose: 90 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
15.6 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/37642857/ |
60 mg single, oral dose: 60 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
2.12 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
7.5 mg single, oral dose: 7.5 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
3.82 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
15 mg single, oral dose: 15 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
9.67 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
30 mg single, oral dose: 30 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
24.3 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
60 mg single, oral dose: 60 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
35.5 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
90 mg single, oral dose: 90 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
3.07 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
7.5 mg 1 times / day multiple, oral dose: 7.5 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
5.85 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
15 mg 1 times / day multiple, oral dose: 15 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
14.9 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
30 mg 1 times / day multiple, oral dose: 30 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
18.2 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
60 mg 1 times / day multiple, oral dose: 60 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
56.6 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
90 mg 1 times / day multiple, oral dose: 90 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
3.61 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/37642857/ |
60 mg single, oral dose: 60 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
1.45 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
7.5 mg single, oral dose: 7.5 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
1.4 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
15 mg single, oral dose: 15 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
1.6 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
30 mg single, oral dose: 30 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
1.98 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
60 mg single, oral dose: 60 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
2.1 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
90 mg single, oral dose: 90 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
1.57 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
7.5 mg 1 times / day multiple, oral dose: 7.5 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
1.68 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
15 mg 1 times / day multiple, oral dose: 15 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
2.02 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
30 mg 1 times / day multiple, oral dose: 30 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
2.37 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
60 mg 1 times / day multiple, oral dose: 60 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
|
2.83 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
90 mg 1 times / day multiple, oral dose: 90 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
Funbound
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
6.5% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34724345/ |
7.5 mg single, oral dose: 7.5 mg route of administration: Oral experiment type: SINGLE co-administered: |
TOLEBRUTINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 01:04:31 GMT 2025
by
admin
on
Wed Apr 02 01:04:31 GMT 2025
|
| Record UNII |
8CZ82ZYY9X
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1971920-73-6
Created by
admin on Wed Apr 02 01:04:31 GMT 2025 , Edited by admin on Wed Apr 02 01:04:31 GMT 2025
|
PRIMARY | |||
|
JK-109
Created by
admin on Wed Apr 02 01:04:31 GMT 2025 , Edited by admin on Wed Apr 02 01:04:31 GMT 2025
|
PRIMARY | |||
|
11268
Created by
admin on Wed Apr 02 01:04:31 GMT 2025 , Edited by admin on Wed Apr 02 01:04:31 GMT 2025
|
PRIMARY | |||
|
124111565
Created by
admin on Wed Apr 02 01:04:31 GMT 2025 , Edited by admin on Wed Apr 02 01:04:31 GMT 2025
|
PRIMARY | |||
|
C173549
Created by
admin on Wed Apr 02 01:04:31 GMT 2025 , Edited by admin on Wed Apr 02 01:04:31 GMT 2025
|
PRIMARY | |||
|
300000023647
Created by
admin on Wed Apr 02 01:04:31 GMT 2025 , Edited by admin on Wed Apr 02 01:04:31 GMT 2025
|
PRIMARY | |||
|
8CZ82ZYY9X
Created by
admin on Wed Apr 02 01:04:31 GMT 2025 , Edited by admin on Wed Apr 02 01:04:31 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |